U.S. Congress legislation · 119th Congress
HB8205: Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Status: Signed into law, November 3, 2026
To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.
What the bill says
An act To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.
From the amended text, July 23, 2026:
AN ACT To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes. SECTION 1. Short title This Act may be cited as the Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 . SECTION 2. Reauthorization of Accelerating Access to Critical Therapies for ALS Act (a) In general Section 7 of the Accelerating Access to Critical Therapies for ALS Act ( Public Law 117-79 ) is amended by striking 2026 and inserting 2031 . (b) Grants for ALS research Section 2(f) of the Accelerating Access to Critical Therapies for ALS Act ( 21 U.S.C. 360ee note) is amended by striking 2026 and inserting 2031 . SECTION 3. Improvements to program for grants for research on therapies for ALS (a) Renewal of grants for research on therapies for ALS review Section 2(b) of the Accelerating Access to Critical Therapies for ALS Act ( 21 U.S.C. 360ee note) is amended by adding at the end the following: (4) Renewal of grants for research on therapies for ALS review In reviewing applications for renewals of a grant awarded under this section with respect to an investigational drug, the Secretary shall request from the manufacturer or sponsor, and assess, the enrollment, safety, and any available efficacy …
Sponsors
- Mike Quigley (D, HD-005) · primary sponsor
- Ken Calvert (R, HD-CA-41)
- Brian Fitzpatrick (R, HD-001)
- Janice Schakowsky (D, HD-009)
- Michael McCaul (R, HD-010)
- Jake Auchincloss (D, HD-004)
- Scott DesJarlais (R, HD-004)
- Angela Craig (D, HD-MN-2)
- David Valadao (R)
- Jason Crow (D, HD-006)
- Glenn Thompson (R, HD-PA-15)
- Gwen Moore (D, HD-004)
Latest actions
- : Signed by President.
- : Presented to President.
- : Message on Senate action sent to the House.
- : Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote. (consideration: CR S5120)
- : Passed Senate without amendment by Voice Vote. (consideration: CR S5120)
- : Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
- : Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.
- : Motion to reconsider laid on the table Agreed to without objection.
- : On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- : Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Subjects: Health programs administration and funding, Public-private cooperation, Neurological disorders, Research administration and funding, Drug therapy, National Institutes of Health (NIH), Internet, web applications, social media, Government information and archives
Common questions
- What is HB8205?
- HB8205 is a bill in Congress (119th Congress): Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026.
- What does HB8205 do?
- In its own words: An act To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.
- What is the status of HB8205?
- Signed into law as of November 3, 2026. Latest action: Signed by President. (November 3, 2026).
- Who sponsored HB8205?
- Mike Quigley (D, HD-005), with 11 co-sponsors.
- Where is the official record for HB8205?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/8205
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.